In a significant step towards strengthening the integrity and transparency of India's drugs regulatory system, the Union Ministry of Health & Family Welfare has notified amendments to the Drugs Rules, 1945 through G.S.R number 756 (E), dated the 16th October, 2025.

In addition to existing enforcement provisions under the Drugs and Cosmetics Act, 1940, these newly notified provisions empower the Licensing Authority to debar further applications by entities who submit fake or fabricated data in support of their applications. This will apply to all applications filed under various provisions of the Drugs Rules 1945.

Presently an applicant submitting fabricated data faces enforcement actions such as rejection of applications and/or cancellation of existing licenses. With this amendment, they would be debarred from filing further applications with the concerned regulatory authority, either State or the Centre (as applicable) for a specified period of time. A due process has been prescribed through the issuance of a show-cause notice before any such punitive action is taken. There is also a provision for appeal provided.

Sound scientific data submitted by applicants forms the basis for regulatory evaluation of the quality, safety and efficacy of drugs. Submission of fake or fabricated data compromises the integrity of the regulatory process, casts aspersions over the quality of drugs and may pose serious risks to public health. The present amendment is intended to deter such misconduct, strengthen accountability among applicants and ensure that approvals of drugs are backed by reliable and scientifically valid evidence.

The notification is in line with the Government's efforts to strengthen India's regulatory framework in accordance with global best practices. It aims to promote those drugs manufacturers and distributors who are compliant with regulatory framework of the country and endeavours to deal with any reported instances of malpractice. It complements the ongoing regulatory reform in the pharmaceutical domain with renewed focus on enhancing oversight, promoting ethical practices and ensuring that unscrupulous entities are adequately penalized. 

The complete text of G.S.R. is available on the Official Gazette (e-Gazette) of the Government of India and can also be accessed through:-

 https://egazette.gov.in/WriteReadData/2026/275233.pdf

*****

SR

HFW/Amendment to Drug Rules 1945 /6 August 2026/1